Biochemicals margin expansion to 7.7% (from 4.5% YoY)
What: Higher specialty product mix driving 76.7% EBITDA growth in biochemicals segment
“EBITDA margin of bio-based chemicals improved to 7.7% in Q3 FY '26 compared to 4.5% in the corresponding quarter last year.”